VCYT ▲ +1.0% - Veracyte, Inc.
$VCYT - Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026
19-OCT-2026 08:00 AM ET
Share this post
More filings for $VCYT
VCYT ▲ +2.5% - Veracyte, Inc.Oct 16, 2026VCYT ▲ +0.9% - Veracyte, Inc.Oct 14, 2026VCYT ▲ +0.8% - Veracyte, Inc.Sep 29, 2026VCYT ▼ -6.5% - Veracyte, Inc.Sep 25, 2026VCYT ▲ +0.7% - Veracyte, Inc.Sep 1, 2026
View full $VCYT filing history →💬 Comments
Loading comments…
Leave a comment